UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.78 +0.30 (+0.38%) GOLD FUTURES
2,323.90 -7.30 (-0.31%) DOW
38,898.47 +46.20 (+0.12%) Bitcoin GBP
50,721.82 +44.09 (+0.09%)
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:42PM EDT. Market open.
| Previous close | 5.27 |
| Open | 5.38 |
| Bid | 5.37 x 1900 |
| Ask | 5.40 x 200 |
| Day's range | 5.24 - 5.70 |
| 52-week range | 4.03 - 8.96 |
| Volume | |
| Avg. volume | 3,381,419 |
| Market cap | 1.113B |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript May 6, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23. BCRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]
- Simply Wall St.
BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
BioCryst Pharmaceuticals ( NASDAQ:BCRX ) First Quarter 2024 Results Key Financial Results Revenue: US$92.8m (up 35...
- GuruFocus.com
BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Discover how BioCryst Pharmaceuticals Inc (BCRX) navigated the first quarter of 2024, with detailed financial results and strategic updates.
© 2024 Yahoo. All rights reserved.